Skip to main content
. 2022 May 25;20(9):1379–1390. doi: 10.1158/1541-7786.MCR-22-0165

Figure 4.

Figure 4. Targeting MUC1-C suppresses ASCL1, NEUROD1, and YAP1 expression. A, Lysates from H69/tet-MUC1shRNA cells treated with vehicle or DOX for 7 days were immunoblotted with antibodies against the indicated proteins. B, Lysates from H69/CsgRNA, H69/MUC1sgRNA#1, and H69/MUC1sgRNA#2 cells were immunoblotted with antibodies against the indicated proteins. C, Lysates from DMS53/tet-MUC1shRNA cells treated with vehicle or DOX for 7 days were immunoblotted with antibodies against the indicated proteins. D and E. Lysates from H69/tet-MYCshRNA (D) and DMS53/tet-MYCshRNA (E) cells treated with vehicle or DOX for 7 days were immunoblotted with antibodies against the indicated proteins. F and G. Lysates from COR-L279/tet-MUC1shRNA (F) and H526/tet-MUC1shRNA (G) cells treated with vehicle or DOX for 7 days were immunoblotted with antibodies against the indicated proteins.

Targeting MUC1-C suppresses ASCL1, NEUROD1, and YAP1 expression. A, Lysates from H69/tet-MUC1shRNA cells treated with vehicle or DOX for 7 days were immunoblotted with antibodies against the indicated proteins. B, Lysates from H69/CsgRNA, H69/MUC1sgRNA#1, and H69/MUC1sgRNA#2 cells were immunoblotted with antibodies against the indicated proteins. C, Lysates from DMS53/tet-MUC1shRNA cells treated with vehicle or DOX for 7 days were immunoblotted with antibodies against the indicated proteins. D and E, Lysates from H69/tet-MYCshRNA (D) and DMS53/tet-MYCshRNA (E) cells treated with vehicle or DOX for 7 days were immunoblotted with antibodies against the indicated proteins. F and G, Lysates from COR-L279/tet-MUC1shRNA (F) and H526/tet-MUC1shRNA (G) cells treated with vehicle or DOX for 7 days were immunoblotted with antibodies against the indicated proteins.